KPV Research for Gut Inflammation
An evidence-based overview of research examining KPV in the context of gut inflammation. This page synthesizes findings from peer-reviewed literature.
Research Summary
KPV reduced inflammatory markers in experimental intestinal models. The C-terminal motif occurs in alpha-MSH, but this does not establish KPV as an effective drug or a clinically relevant gut hormone. Oral KPV reduced colitis readouts in mice and was transported by PepT1 in studied cells. Human oral bioavailability and benefit are unknown. Interest in KPV for gut health has grown in integrative medicine circles, though clinical evidence supporting such use is lacking.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.